During the past decade, Axis Clinical Trials conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 26 clinical trials were completed, i.e. on average, 104% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 12 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Axis Clinical Trials" #1 sponsor was "Dr. Reddy's Laboratories Limited" with 4 trials, followed by "Sunovion" with 4 trials sponsored, "Aderans Research Institute" with 3 trials sponsored, "AstraZeneca" with 2 trials sponsored and "Ferring Pharmaceuticals" with 2 trials sponsored. Other sponsors include 37 different institutions and companies that sponsored additional 44 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Axis Clinical Trials" #1 collaborator was "Accelovance" with 2 trials as a collaborator, "Syneos Health" with 2 trials as a collaborator, "Alfasigma S.p.A." with 1 trials as a collaborator, "Axis Clinical Trials" with 1 trials as a collaborator and "BARC Global Central Laboratory" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Axis Clinical Trials" are "Androgenetic Alopecia" (5 trials), "Rheumatoid Arthritis" (4 trials), "Female Pattern Baldness" (3 trials), "Head Lice Infestation" (3 trials) and "Heart Failure" (3 trials). Many other conditions were trialed in "Axis Clinical Trials" in a lesser frequency.

Most popular intervention types in "Axis Clinical Trials" are "Drug" (44 trials), "Biological" (5 trials), "Device" (5 trials), "Dietary Supplement" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Lurasidone" (4 trials), "Autologous cultured dermal and epidermal cells" (3 trials), "Abametapir Lotion 0.74% w/w" (2 trials) and "Click Device" (2 trials). Other intervention names were less common.

The vast majority of trials in "Axis Clinical Trials" are 48 trials for "All" genders, 7 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Axis Clinical Trials". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 46 completed trials in Axis Clinical Trials, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Axis Clinical Trials, 6 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".